Company: STAA
Filing Date: 2025-10-02
Form Type: DFAN14A
Source: 0001213900-25-095514
Chunk: 4

Company: STAAR SURGICAL CO
Filing Date: 2025-10-02
Form: DFAN14A
Chunk 4
---
,938 LTM Net Sales ($M) 1 $2,001 LTM Core Op. Income ($M) 1 25,599 Employees 3 Geneva, Switzerland Headquarters ▪ Alcon develops, manufactures and distributes a full suite of eye care products within two business segments: Surgical and Vis ion Care — The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery — The Vision Care segment comprises daily disposable, reusable and color - enhancing contact lenses and a comprehensive portfolio of ocular care health products, including products for dry eye, ocular allergies, glaucoma and contact lens care ▪ Alcon serves consumers and patients in over 140 countries, with more than half of the company’s net sales coming from outside th e U.S. ▪ Alcon’s Surgical portfolio includes equipment (e.g., lasers), disposable patient interfaces and other devices related to LASI K t reatment — Alcon’s refractive business is under threat from newer excimer and femtosecond lasers and from a general shift in demand away fr om LASIK to refractive alternatives, including STAAR’s ICLs 45% 55% United States International 18% 29% 9% 27% 17% Implantables Consumables Equipment / Other Contact Lenses Ocular Health LTM Net Sales Mix by Segment 1 LTM Net Sales Mix by Geography 1 Summary Data

Broadwood Partners, L.P. Overview of the Acquisition of STAAR by Alcon 7 August 5, 2025 Announcement Date Alcon Inc., a NYSE - listed, Swiss - American global leader in eye care, with ~$10 billion in revenue and a $40 billion market capit alization Buyer ▪ $28 per share in cash ▪ ~$1.5 billion in equity value; ~$1.3 billion in total transaction value Consideration ▪ 51% premium to STAAR’s closing stock price on August 4, 2025 (following a 53% decline in STAAR’s stock price over the prior 12 months) ▪ 31% discount to STAAR’s unaffected 52 - week high closing stock price; 83% discount to STAAR’s all - time high closing stock price ▪ 55% discount to the offer price in Alcon’s October 2024 proposal to acquire STAAR Premium / Discount ▪ No proactive outreach to potential alternative buyers,